18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
or 9 11 9 11 O
older 12 17 12 17 O

Abnormal 0 8 18 26 O
liver 9 14 27 32 O
function 15 23 33 41 O
, 23 24 41 42 O
defined 25 32 43 50 O
as 33 35 51 53 O
≥3x 36 39 54 57 O
upper 40 45 58 63 I-lower_bound
limit 46 51 64 69 I-lower_bound
of 52 54 70 72 I-lower_bound
normal 55 61 73 79 I-lower_bound
( 62 63 80 81 I-lower_bound
ULN 63 66 81 84 I-lower_bound
) 66 67 84 85 I-lower_bound
of 68 70 86 88 O
aspartate 71 80 89 98 B-clinical_variable
aminotransferase 81 97 99 115 I-clinical_variable
( 98 99 116 117 I-clinical_variable
AST 99 102 117 120 I-clinical_variable
) 102 103 120 121 I-clinical_variable
, 103 104 121 122 O
alanine 105 112 123 130 B-clinical_variable
aminotransferase 113 129 131 147 I-clinical_variable
( 130 131 148 149 I-clinical_variable
ALT 131 134 149 152 I-clinical_variable
) 134 135 152 153 I-clinical_variable
or 136 138 154 156 O
known 139 144 157 162 O
cirrhosis 145 154 163 172 B-chronic_disease

Acute 0 5 173 178 B-chronic_disease
upper 6 11 179 184 I-chronic_disease
respiratory 12 23 185 196 I-chronic_disease
infection 24 33 197 206 I-chronic_disease
within 34 40 207 213 O
2 41 42 214 215 B-upper_bound
weeks 43 48 216 221 I-upper_bound
or 49 51 222 224 O
acute 52 57 225 230 B-chronic_disease
pulmonary 58 67 231 240 I-chronic_disease
exacerbation 68 80 241 253 I-chronic_disease
requiring 81 90 254 263 O
intravenous 91 102 264 275 B-treatment
antibiotics 103 114 276 287 I-treatment
within 115 121 288 294 O
4 122 123 295 296 B-upper_bound
weeks 124 129 297 302 I-upper_bound
of 130 132 303 305 O
Screening 133 142 306 315 O
Visit 143 148 316 321 O

Any 0 3 322 325 O
change 4 10 326 332 O
in 11 13 333 335 O
chronic 14 21 336 343 B-treatment
therapies 22 31 344 353 I-treatment
for 32 35 354 357 O
CF 36 38 358 360 B-chronic_disease
lung 39 43 361 365 I-chronic_disease
disease 44 51 366 373 I-chronic_disease
( 52 53 374 375 O
e.g. 53 57 375 379 O
, 57 58 379 380 O
Ibuprofen 59 68 381 390 B-treatment
, 68 69 390 391 O
Pulmozyme 70 79 392 401 B-treatment
® 79 80 401 402 I-treatment
, 80 81 402 403 O
hypertonic 82 92 404 414 B-treatment
saline 93 99 415 421 I-treatment
, 99 100 421 422 O
Azithromycin 101 113 423 435 B-treatment
, 113 114 435 436 O
TOBI 115 119 437 441 B-treatment
® 119 120 441 442 I-treatment
, 120 121 442 443 O
Cayston 122 129 444 451 B-treatment
® 129 130 451 452 I-treatment
) 130 131 452 453 O
within 132 138 454 460 O
4 139 140 461 462 B-upper_bound
weeks 141 146 463 468 I-upper_bound
of 147 149 469 471 O
Study 150 155 472 477 O
Day 156 159 478 481 O
1 160 161 482 483 O

Any 0 3 484 487 O
investigational 4 19 488 503 B-treatment
drug 20 24 504 508 I-treatment
or 25 27 509 511 I-treatment
device 28 34 512 518 I-treatment
within 35 41 519 525 O
30 42 44 526 528 B-upper_bound
days 45 49 529 533 I-upper_bound
of 50 52 534 536 O
Screening 53 62 537 546 O
or 63 65 547 549 O
within 66 72 550 556 O
6 73 74 557 558 B-upper_bound
half 75 79 559 563 I-upper_bound
- 79 80 563 564 I-upper_bound
lives 80 85 564 569 I-upper_bound
of 86 88 570 572 O
the 89 92 573 576 O
investigational 93 108 577 592 O
drug 109 113 593 597 O
( 114 115 598 599 O
whichever 115 124 599 608 O
is 125 127 609 611 O
longer 128 134 612 618 O
) 134 135 618 619 O

Clinically 0 10 620 630 O
significant 11 22 631 642 O
cardiac 23 30 643 650 B-chronic_disease
, 30 31 650 651 O
liver 32 37 652 657 B-chronic_disease
or 38 40 658 660 O
kidney 41 47 661 667 B-chronic_disease
disease 48 55 668 675 I-chronic_disease

Confirmed 0 9 676 685 O
diagnosis 10 19 686 695 O
of 20 22 696 698 O
CF 23 25 699 701 B-chronic_disease
based 26 31 702 707 O
on 32 34 708 710 O
the 35 38 711 714 O
following 39 48 715 724 O
criteria 49 57 725 733 O

Current 0 7 734 741 O
use 8 11 742 745 O
of 12 14 746 748 O
ivacaftor 15 24 749 758 B-treatment
( 25 26 759 760 I-treatment
Kalydeco 26 34 760 768 I-treatment
) 34 35 768 769 I-treatment
, 35 36 769 770 O
lumacaftor 37 47 771 781 B-treatment
/ 47 48 781 782 I-treatment
ivacaftor 48 57 782 791 I-treatment
combination 58 69 792 803 O
, 69 70 803 804 O
or 71 73 805 807 O
other 74 79 808 813 O
corrector 80 89 814 823 B-treatment
or 90 92 824 826 I-treatment
potentiator 93 104 827 838 I-treatment
( 105 106 839 840 I-treatment
Symdeko 106 113 840 847 I-treatment
) 113 114 847 848 I-treatment
less 115 119 849 853 O
than 120 124 854 858 O
30 125 127 859 861 B-upper_bound
days 128 132 862 866 I-upper_bound
from 133 137 867 871 O
Screening 138 147 872 881 O

FEV1 0 4 882 886 B-clinical_variable
greater 5 12 887 894 O
than 13 17 895 899 O
30 18 20 900 902 B-lower_bound
% 20 21 902 903 I-lower_bound
predicted 22 31 904 913 O
normal 32 38 914 920 O
for 39 42 921 924 O
age 43 46 925 928 B-age
, 46 47 928 929 O
gender 48 54 930 936 O
, 54 55 936 937 O
height 56 62 938 944 O
( 63 64 945 946 O
Hankinson 64 73 946 955 O
standards 74 83 956 965 O
) 83 84 965 966 O
pre 85 88 967 970 O
or 89 91 971 973 O
post 92 96 974 978 O
- 96 97 978 979 O
bronchodilator 97 111 979 993 O
at 112 114 994 996 O
Screening 115 124 997 1006 O

History 0 7 1007 1014 O
of 8 10 1015 1017 O
or 11 13 1018 1020 O
listed 14 20 1021 1027 O
for 21 24 1028 1031 O
solid 25 30 1032 1037 B-treatment
organ 31 36 1038 1043 I-treatment
or 37 39 1044 1046 O
hematological 40 53 1047 1060 B-treatment
transplantation 54 69 1061 1076 I-treatment

If 0 2 1077 1079 O
of 3 5 1080 1082 O
childbearing 6 18 1083 1095 O
potential 19 28 1096 1105 O
, 28 29 1105 1106 O
agree 30 35 1107 1112 B-contraception_consent
to 36 38 1113 1115 I-contraception_consent
use 39 42 1116 1119 I-contraception_consent
one 43 46 1120 1123 I-contraception_consent
highly 47 53 1124 1130 I-contraception_consent
effective 54 63 1131 1140 I-contraception_consent
method 64 70 1141 1147 I-contraception_consent
of 71 73 1148 1150 I-contraception_consent
contraception 74 87 1151 1164 I-contraception_consent
from 88 92 1165 1169 O
the 93 96 1170 1173 O
time 97 101 1174 1178 O
of 102 104 1179 1181 O
consent 105 112 1182 1189 O
through 113 120 1190 1197 O
the 121 124 1198 1201 O
Visit 125 130 1202 1207 O
4 131 132 1208 1209 O
study 133 138 1210 1215 O
visit 139 144 1216 1221 O
, 144 145 1221 1222 O
per 146 149 1223 1226 O
section 150 157 1227 1234 O
9.1.13 158 164 1235 1241 O
of 165 167 1242 1244 O
the 168 171 1245 1248 O
protocol 172 180 1249 1257 O

Male 0 4 1258 1262 B-gender

Negative 0 8 1263 1271 B-pregnancy
pregnancy 9 18 1272 1281 I-pregnancy
test 19 23 1282 1286 O
for 24 27 1287 1290 O
women 28 33 1291 1296 B-gender
of 34 36 1297 1299 O
child 37 42 1300 1305 O
- 42 43 1305 1306 O
bearing 43 50 1306 1313 O
potential 51 60 1314 1323 O

Oxygen 0 6 1324 1330 B-clinical_variable
saturation 7 17 1331 1341 I-clinical_variable
by 18 20 1342 1344 O
pulseoximetry 21 34 1345 1358 O
90 35 37 1359 1361 B-lower_bound
% 37 38 1361 1362 I-lower_bound
or 39 41 1363 1365 O
greater 42 49 1366 1373 O
breathing 50 59 1374 1383 O
ambient 60 67 1384 1391 O
air 68 71 1392 1395 O
or 72 74 1396 1398 O
regular 75 82 1399 1406 O
oxygen 83 89 1407 1413 O
regimen 90 97 1414 1421 O
at 98 100 1422 1424 O
screening 101 110 1425 1434 O
and 111 114 1435 1438 O
day 115 118 1439 1442 O
1 119 120 1443 1444 O

Pregnant 0 8 1445 1453 B-pregnancy
, 8 9 1453 1454 O
planned 10 17 1455 1462 B-pregnancy
pregnancy 18 27 1463 1472 I-pregnancy
or 28 30 1473 1475 O
breast 31 37 1476 1482 O
feeding 38 45 1483 1490 O

Seizure 0 7 1491 1498 B-chronic_disease
disorder 8 16 1499 1507 I-chronic_disease

Sinus 0 5 1508 1513 B-treatment
surgery 6 13 1514 1521 I-treatment
within 14 20 1522 1528 O
6 21 22 1529 1530 B-upper_bound
weeks 23 28 1531 1536 I-upper_bound
of 29 31 1537 1539 O
Screening 32 41 1540 1549 O
Visit 42 47 1550 1555 O

Subjects 0 8 1556 1564 O
on 9 11 1565 1567 O
chronic 12 19 1568 1575 B-treatment
inhaled 20 27 1576 1583 I-treatment
antibiotic 28 38 1584 1594 I-treatment
therapy 39 46 1595 1602 I-treatment
are 47 50 1603 1606 O
eligible 51 59 1607 1615 O
if 60 62 1616 1618 O
they 63 67 1619 1623 O
can 68 71 1624 1627 O
continue 72 80 1628 1636 O
their 81 86 1637 1642 O
usual 87 92 1643 1648 O
antibiotic 93 103 1649 1659 B-treatment
regimen 104 111 1660 1667 I-treatment
, 111 112 1667 1668 O
or 113 115 1669 1671 O
remain 116 122 1672 1678 O
on 123 125 1679 1681 O
their 126 131 1682 1687 O
off 132 135 1688 1691 O
- 135 136 1691 1692 O
cycle 136 141 1692 1697 O
period 142 148 1698 1704 O
, 148 149 1704 1705 O
for 150 153 1706 1709 O
the 154 157 1710 1713 O
duration 158 166 1714 1722 O
of 167 169 1723 1725 O
study 170 175 1726 1731 O
drug 176 180 1732 1736 O
exposure 181 189 1737 1745 O

Taking 0 6 1746 1752 O
pancreatic 7 17 1753 1763 B-treatment
enzyme 18 24 1764 1770 I-treatment
replacement 25 36 1771 1782 I-treatment
therapy 37 44 1783 1790 I-treatment
( 45 46 1791 1792 I-treatment
PERT 46 50 1792 1796 I-treatment
) 50 51 1796 1797 I-treatment

female 0 6 1798 1804 B-gender

